Only Available By Prescription
Sign up to get notified if we do in the future.
We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Taldefgrobep alfa is a fully human recombinant protein designed to inhibit myostatin and activin A signaling—two key regulators of muscle mass and adipose tissue. By binding to myostatin and acting as an activin receptor antagonist, it aims to increase muscle mass and reduce fat accumulation. Taldefgrobep is being developed as an adjunctive therapy for spinal muscular atrophy (SMA) and is also under investigation for potential use in obesity management.
Taldefgrobep alfa is administered via subcutaneous injection. In the RESILIENT Phase 3 trial for SMA, dosing was conducted over a 48-week period. Specific dosing regimens are determined based on patient weight and clinical protocol. The therapy is intended as an adjunct to existing SMA treatments such as nusinersen, risdiplam, or onasemnogene abeparvovec-xioi. Administration should be supervised by healthcare professionals experienced in managing neuromuscular disorders.
Active ingredient:
Inactive ingredients:
As of the latest clinical data, no specific contraindications have been identified. However, patients with known hypersensitivity to recombinant proteins or any component of the formulation should exercise caution. Further evaluation is ongoing to establish comprehensive safety profiles.
In clinical trials, taldefgrobep alfa was generally well-tolerated. Reported side effects include:
No treatment-related serious adverse events (SAEs) were reported in the RESILIENT trial, and 97% of participants continued into the optional long-term extension phase.
Exceptional Customer Service
We pride ourselves on delivering excellent customer service with as much accessibility as possible.
If you have any questions at all, or would like to place an order, you are encouraged to contact us by toll-free
phone 1-888-904-8467 or email info@canadadrugsdirect.com.
Top Safety and Quality
Canada Drugs Direct employs dedicated, professional licensed pharmacists to ensure that each and every order is reviewed before it is dispensed for the safety and health of our customers. At CanadaDrugsDirect.com, your health is our top priority.
Product Reviews